Itama Ranoraya (IRRA) - Total Liabilities

Latest as of September 2025: Rp2.16 Trillion IDR ≈ $126.85 Million USD

Based on the latest financial reports, Itama Ranoraya (IRRA) has total liabilities worth Rp2.16 Trillion IDR (≈ $126.85 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Itama Ranoraya - Total Liabilities Trend (2016–2024)

This chart illustrates how Itama Ranoraya's total liabilities have evolved over time, based on quarterly financial data. See IRRA net working capital ratio to evaluate short-term liquidity relative to the company's equity base.

Itama Ranoraya Competitors by Total Liabilities

The table below lists competitors of Itama Ranoraya ranked by their total liabilities.

Company Country Total Liabilities
Reckon Ltd
AU:RKN
Australia AU$31.24 Million
Avonmore Capital & Management Services Limited
NSE:AVONMORE
India Rs757.90 Million
InspireMD Inc
NASDAQ:NSPR
USA $12.85 Million
JAS Asset PCL
BK:J
Thailand ฿3.18 Billion
Latrobe Magnesium Ltd
AU:LMG
Australia AU$43.04 Million
Duksung
KO:004830
Korea ₩64.30 Billion
Avertronics
TWO:3597
Taiwan NT$1.01 Billion

Liability Composition Analysis (2016–2024)

This chart breaks down Itama Ranoraya's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see IRRA stock market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 1.90 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 3.89 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.80 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Itama Ranoraya's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Itama Ranoraya (2016–2024)

The table below shows the annual total liabilities of Itama Ranoraya from 2016 to 2024.

Year Total Liabilities Change
2024-12-31 Rp1.15 Trillion
≈ $67.19 Million
+91.21%
2023-12-31 Rp599.69 Billion
≈ $35.14 Million
+139.99%
2022-12-31 Rp249.88 Billion
≈ $14.64 Million
-10.75%
2021-12-31 Rp279.99 Billion
≈ $16.41 Million
-4.42%
2020-12-31 Rp292.94 Billion
≈ $17.17 Million
+224.54%
2019-12-31 Rp90.26 Billion
≈ $5.29 Million
+29.66%
2018-12-31 Rp69.62 Billion
≈ $4.08 Million
-16.45%
2017-12-31 Rp83.32 Billion
≈ $4.88 Million
+407.44%
2016-12-31 Rp16.42 Billion
≈ $962.18K
--

About Itama Ranoraya

JK:IRRA Indonesia Medical Distribution
Market Cap
$33.22 Million
Rp566.94 Billion IDR
Market Cap Rank
#23437 Global
#471 in Indonesia
Share Price
Rp376.00
Change (1 day)
+2.17%
52-Week Range
Rp330.00 - Rp510.00
All Time High
Rp3619.99
About

PT Itama Ranoraya Tbk wholesale trades in laboratory and pharmaceutical equipment, and medical devices for humans in Indonesia. The company offers in vitro diagnostics products comprising rapid test and clinical laboratory; medical imaging products, including bone densitometer, C-arm, flat panel digital detector, mobile and stationary x-ray, and mammography; cardiovascular, urology, and surgical … Read more